Trade Summary

2 days ago, Norden Gregory, serving as Dir at Royalty Pharma Plc (RPRX), sold 3,045 shares at $53.00 per share, for a total transaction value of $161,385.00. Following this transaction, Norden Gregory now holds 191,803 shares of RPRX.

This sale represents a 2.00% decrease in Norden Gregory's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 4:37 PM ET, 1 day after the trade was made.

Royalty Pharma Plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.